Professor Don Jeffries, Chair of the Advisory Committee on Dangerous Pathogens Working Group on Transmissible Spongiform Encephalopathies (ACDP TSE), Deputy Chair of the Creutzfeldt-Jakob Disease (CJD) Incidents Panel, and Chair of the Department of Health Decontamination Research Group discusses the latest guidance on the prevention of transmissible spongiform encephalopathies (TSEs). This article is based on the presentation he gave at AfPP's Annual Congress in October 2005.
ACDP TSE Working Group Guidelines Annex F Endoscopy2005 Available from: www.advisorybodies.doh.gov.uk [accessed 27 March 2006]
3.
Advisory Committee on Dangerous Pathogens/Spongiform Encephalopathy Advisory Committee,1998Transmissible Spongiform Encephalopathy Agents: Safe Working and Prevention of InfectionLondon, The Stationary Office
4.
BaxterH.C., CampbellG.A., WhittakerA.G.2005Elimination of transmissible spongiform encephalopathy infectivity and decontamination surgical instruments by using radio frequency gas plasma treatmentThe Journal of General Virology86(8) 2393–2399
5.
BrownP., PreeceM., BrandelJ.P.2000Latrogenic Creutzfeldt-Jakob disease at the millenniumNeurology55(8) 1075–1081
De ArmondC.I., PrusinerS.B.2003Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatmentClinics in Laboratory Medicine23(1) 1–41
9.
DonnellyC.A., FergusonN.M., GhaniA.C., AndersonR.M.2002Implications of BSE infection screening data for the scale of the current British BSE epidemic and the current European infection levelsProceedings. Biological Sciences/The Royal Society269(1506) 2179–2190
10.
EOR Surgical Instruments Risk Assessment2000 Available from: www.doh.gov.uk/cjd [accessed 27 March 2006]
11.
ESOR Assessing the risk of vCJD transmission via surgery: an interim review2005 Available from: www.dh.gov.uk/PublicationsAndStatistics [accessed 27 March 2006]
12.
HillA.F., ButterworthR.J., JoinerS.1999Investigations of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samplesLancet353(9148) 183–189
13.
HiltonD.A., GhaniA.C., ConyersL.2004Prevalence of lymphoreticular prion protein accumulation in UK tissue samplesJournal of Pathology203(3) 733–739
14.
HunterN., FosterJ., ChongA.2002Transmission of prion diseases by blood transfusionJournal of General Virology832897–2905
15.
IronsideJ.W.2006Variant Creutzfeldt-Jakob disease risk of transmission by blood transfusion and blood therapiesHaemophilia (12 Supp 1) 8–15
16.
LlewelynC.A.2004Possible transmission of variant CJD by blood transfusionLancet365417–421
17.
MastersC.L., HarrisJ.O., GadjusekD.C., GibbsC.J.Jr, BernoulliC., AsherD.M.1979Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clusteringAnnals of Neurology5(2) 177–188
18.
National CJD Surveillance Unit (NCJDU)2006 Available from: www.cjd.ed.ac.uk [accessed 27 March 2006]
19.
PrusinerS.B.2001Shattuck lecture: neurodegenerative diseases and prionsThe New England Journal of Medicine344(20) 1516–1526
20.
TaylorD.M.2000Inactivation of transmissible degenerative encephalopathy agents: a reviewVeterinary Journal159(1) 10–17
21.
WadsworthJ.D., JoinerS., HillA.F.2001Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assayLancet358(9277) 171–180
22.
WillR.G., AlperovitchA., PoserS.1998Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995Annuls of Neurology43(6) 763–767
